Temerty Faculty of Medicine
Search this site
Menu
Interventional Study

VRN-AD

Get in touch about this study
Study Investigator:Dr. Harmehr Sekhon
Site: Centre for Addiction and Mental Health  | Address: 1001 Queen St W, Toronto, ON M6J 1H4
Area of Focus: Alzheimer’s disease
Minimum Participant Age: 50+

Full study title: Nature-based Virtual Reality Intervention for Depression in Alzheimer’s Disease

 

What is the study about?

This study looks at how an at-home nature-based virtual reality (VR) program may help people living with Alzheimer’s Disease manage behavioural and psychological symptoms of dementia (BPSD), such as depression. Caregivers and/or study partners will have the option of taking part in the study and providing feedback regarding the VR intervention. This project will explore how virtual reality can be used as a non-pharmacological approach to prolong aging in place for individuals with BPSD, as BPSD contributes to rates of institutionalization.

 

Eligibility – Who can participate?

Participants must:

  • Be 50 years of age
  • Clinical diagnosis of mild to early-moderate stage Alzheimer’s Disease (AD) (including mixed dementia with AD)
  • Medical stability to participate in the trial
  • Investigator judgement on whether the participant is comfortable with technology
  • Access to WiFi and a smart device for connecting on WebEx and downloading the Fitbit and Muse applications
  • Have someone available to be present during all sessions

 

Time requirement

  • 4 weeks
  • 2 intervention sessions per week
Logo for Centre for Addiction and Mental Health

Related Studies

Interventional Study

Nabilone for Agitation Blinded Intervention Trial (NAB-IT)

This study will look at nabilone as a treatment for agitation in persons with Alzheimer’s disease (AD).
Alzheimer’s disease
Multi-site (4)
Interventional Study

rTMS Apathy Clinical Trial (REACT)

Apathy is a common, early, and disabling symptom in dementias such as Alzheimer’s disease (AD) and is characterized by lack of interest and enthusiasm. 
Alzheimer’s disease |  Frontotemporal dementia (FTD) |  Vascular dementia
Sunnybrook Health Sciences Centre
Interventional Study

CT Radiation Study

This study is a randomized control trial that is trying to find out whether the radiation from repeated CT scans can temporarily improve the functioning, memory, thinking, and/or behaviour in people with advanced dementia. 
Alzheimer’s disease |  Dementia with Lewy bodies (DLB) |  Frontotemporal dementia (FTD) |  Parkinson’s disease |  Vascular dementia
Baycrest

Can't find a study you're interested in?

Give us your feedback

Do you have questions about research studies you saw on this page? 
Please contact tdra@utoronto.ca

Disclaimer

The listing of a study on the TDRA’s Research Studies Portal is for informational purposes only. The safety, efficacy or scientific validity of the studies listed here have not been evaluated by The Alzheimer Society of Toronto (AST) or the Toronto Dementia Research Alliance (TDRA). The TDRA is an academic coalition among the University of Toronto and Baycrest, the Centre for Addiction and Mental Health, Ontario Shores Centre for Mental Health Sciences, Sunnybrook Health Sciences Centre, and the University Health Network. The information collected will be kept and guarded by TDRA. Choosing to participate in a study is an important personal decision. Before you participate in a study, you should make sure you understand the risks and potential benefits and discuss all options with your health care provider(s).